Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| 1 |
Apple
AAPL
|
+$3.33B |
| 2 |
NVIDIA
NVDA
|
+$1.99B |
| 3 |
Visa
V
|
+$1.04B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.04B |
| 5 |
Amazon
AMZN
|
+$964M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.52B |
| 3 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$1.07B |
| 4 |
iShares MSCI India ETF
INDA
|
+$871M |
| 5 |
CrowdStrike
CRWD
|
+$796M |
Sector Composition
| 1 | Technology | 21.76% |
| 2 | Consumer Discretionary | 9.86% |
| 3 | Financials | 9.03% |
| 4 | Healthcare | 6.97% |
| 5 | Industrials | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3076
Renasant Corp
RNST
$3.56B
| $1.49M | ﹤0.01% |
48,887
-52,557
| -52% | -$1.61M |
|
3077
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$81.7M
| $1.49M | ﹤0.01% |
203,547
+54,004
| +36% | +$396K |
|
3078
First Commonwealth Financial
FCF
$1.8B
| $1.49M | ﹤0.01% |
107,958
+96,663
| +856% | +$1.33M |
|
3079
First Trust Managed Futures Strategy Fund
FMF
$178M
| $1.49M | ﹤0.01% |
30,605
-30,850
| -50% | -$1.5M |
|
3080
Triple Flag Precious Metals
TFPM
$5.73B
| $1.49M | ﹤0.01% |
95,960
+25,685
| +37% | +$398K |
|
3081
Invesco Agriculture Commodity Strategy No K-1 ETF
PDBA
$67M
| $1.49M | ﹤0.01% |
43,237
-19,027
| -31% | -$655K |
|
3082
Pediatrix Medical
MD
$1.4B
| $1.49M | ﹤0.01% |
+196,951
| New | +$1.49M |
|
3083
Innovator US Equity Ultra Buffer ETF February
UFEB
$241M
| $1.49M | ﹤0.01% |
+46,940
| New | +$1.49M |
|
3084
iShares MSCI Peru and Global Exposure ETF
EPU
$182M
| $1.49M | ﹤0.01% |
+36,936
| New | +$1.49M |
|
3085
Cassava Sciences
SAVA
$100M
| $1.48M | ﹤0.01% |
120,148
+23,761
| +25% | +$293K |
|
3086
Ares Capital
ARCC
$14.9B
| $1.48M | ﹤0.01% |
71,119
-111,314
| -61% | -$2.32M |
|
3087
DiamondRock Hospitality
DRH
$1.68B
| $1.48M | ﹤0.01% |
175,040
+159,244
| +1,008% | +$1.35M |
|
3088
Xtrackers US National Critical Technologies ETF
CRTC
$119M
| $1.48M | ﹤0.01% |
+48,572
| New | +$1.48M |
|
3089
iShares iBonds Dec 2031 Term Treasury ETF
IBTL
$427M
| $1.48M | ﹤0.01% |
73,986
+5,861
| +9% | +$117K |
|
3090
United States 12 Month Natural Gas Fund
UNL
$10.6M
| $1.48M | ﹤0.01% |
178,804
+55,952
| +46% | +$462K |
|
3091
Clover Health Investments
CLOV
$1.6B
| $1.48M | ﹤0.01% |
1,200,333
+581,425
| +94% | +$715K |
|
3092
Ramaco Resources Class A
METC
$1.7B
| $1.48M | ﹤0.01% |
122,525
-64,185
| -34% | -$773K |
|
3093
Hyster-Yale Materials Handling
HY
$636M
| $1.47M | ﹤0.01% |
21,128
+11,986
| +131% | +$836K |
|
3094
Safe Bulkers
SB
$467M
| $1.47M | ﹤0.01% |
252,825
+173,275
| +218% | +$1.01M |
|
3095
Viridian Therapeutics
VRDN
$1.52B
| $1.47M | ﹤0.01% |
113,075
+63,393
| +128% | +$825K |
|
3096
Transcat
TRNS
$670M
| $1.47M | ﹤0.01% |
12,288
+10,243
| +501% | +$1.23M |
|
3097
BondBloxx Bloomberg Twenty Year Target Duration US Treasury ETF
XTWY
$75.3M
| $1.47M | ﹤0.01% |
+35,746
| New | +$1.47M |
|
3098
Vontier
VNT
$6.25B
| $1.47M | ﹤0.01% |
38,381
+30,776
| +405% | +$1.18M |
|
|
BRKL
3099
DELISTED
Brookline Bancorp
BRKL
| $1.47M | ﹤0.01% |
175,585
+139,832
| +391% | +$1.17M |
|
3100
Summit Therapeutics
SMMT
$13.4B
| $1.47M | ﹤0.01% |
187,845
+48,344
| +35% | +$377K |
|